Ann: Private equity discussions cease , page-19

Thank you for your comments. Yes I think that most health stocks are at risk in the longer term. I saw the recent cutbacks in opthalmology as the beginning. This morning at the pathologist I was informed that I would no longer be bulk billed but charged up to a gap of $80. In the short term I think stocks like VGH will do very well as they have been oversold, but I am concerned that the government is running out of money and will need to cut health expenditures. This is the opposite to what is being reported in the media, and so frustration may have driven my comments last week. To post my sentiment more accuratley VGH S/T buy, then a L/T sell.